Navigation Links
BioMed Realty Trust to Present at Citi 2009 Global Property CEO Conference
Date:3/2/2009

SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at the Citi 2009 Global Property CEO Conference in Naples, Florida at approximately 9:05 a.m. Eastern Standard Time on Wednesday, March 4, 2009.

The presentation will be open to all investors by calling 719.785.5595 and providing the passcode 348395.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty Trust owns or has interests in 69 properties, representing 112 buildings with approximately 10.4 million rentable square feet, including approximately 1.4 million square feet of development in progress. The company also owns undeveloped land parcels adjacent to existing properties that it estimates can support up to 1.4 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.


'/>"/>
SOURCE BioMed Realty Trust, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Divisions Hyperbaric Chambers Address U.S. President Obamas Initiative to Computerize Medical Records
2. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Monoplace Hyperbaric Chambers
3. Sinobiomed Announces New Executive Team
4. BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors
5. BioMed Realty Trust to Report 2008 Fourth Quarter and Year-End Results
6. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
7. Origin BioMed Awarded Red Herring Top 100 Global Company
8. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
9. Bavarian Nordics Case Against Oxford BioMedica
10. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
11. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...noticefrom,theNasdaqStockMarketthattradinginthecom...09andaForm25-NSEwillbefiledwiththe,SecuritiesandEx...k,fromlistingonNasdaq,unlessthecompanyfilesanappea...hasfiledsuchanappeal,which,willstaythesuspensionan...
(Date:11/24/2009)...Newswire-Asia/--NODPharmaceuticalsInc.announced,th...entapplicationfor,itsnano-particleoraldeliveryorNO...tapproachtoincorporatepeptidesor,proteinsintobio-a...therwiseadministeredasinjections.NODtechnologyisap...ulardrugssuchasinsulin,interferon,growthhormone,e...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
(Date:11/24/2009)...09/PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc...heduledtopresentatthePiperJaffray21stAnnualHealthC...e(8:30a.m.PacificTime)attheNewYorkPalaceHotelinNew...iveOfficer,isscheduledtoprovideanoverviewofthecomp...grams. ,, Aliveaudiowebcastofthepresentationwil...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...ransfer Paves the Way for the Phase III Clinical D...00 in Developing Countries, LEUVEN, Belgium, Sept..., a biotechnology company focused on vascular dise...the technology transfer to Bharat,Biotech Internat...re of,THR-100, a novel variant of Recombinant Stap...
...EIJING, Sept. 3 /Xinhua-PRNewswire-FirstCall/ -- C...asdaq: CMED ), a leading China-based,medical devi... advanced in-,vitro diagnostic products and high i... today announced that it will participate in Credi...a Day. Location: Shenzhen, China Date:...
...ARIS, September 2 Sanofi-aventis announced,today ...IMI 25 and STEEPLE,studies confirm clear net clini...vation myocardial infarction (STEMI) for Lovenox(R...IMI 25 and STEEPLE one year results were presented...f Cardiology (ESC) Congress in,Vienna, Austria. E...
Other Biology Technology:ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 2New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 3New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 5
(Date:11/23/2009)... , DURHAM, N.H. University of New Hampshire mi...taling $498,115 to advance understanding of the ac...tential to enrich nutrient-poor and contaminated s...ture (USDA) awarded Tisa, a professor of molecular...plore the symbiotic relationship between the bacte...
(Date:11/23/2009)... , , University of Southern California biomedical...s to develop a new tool to help clinicians disting...ry from chronic problems manageable with drugs and...catheters inserted into the arteries feeding the h... ("lumen") of these blood vessels, often revealing...
(Date:11/23/2009)... , Amphibians like frogs and toads have existed f...rs didn,t, but a new aquatic fungus is threatening...icle in the November issue of Microbiology Today ... (Bd), was found to be associated with waves of a...eastern Australia in the 1990,s. Bd infects over 3...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2H D Smith Promotes Leadership to Fill Two Senior Roles 51210 1H D Smith Promotes Leadership to Fill Two Senior Roles 51210 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3
...ngineers at MIT are developing a tiny sensor that ...dous gases, including toxic industrial chemicals a... current devices. , The researchers have taken th... spectrometry and shrunk them to fit in a device t... led by MIT Professor Akintunde Ibitayo Akinwande,...
...tes Xie Lab has published findings that begin to c...g stem cells within their cellular microenvironme...ays issue of Cell Stem Cell. , The Xie Lab demon...ovarian germline stem cells (GSCs), behaving like ...em cells for a position in the niche. They do so b...
... NY Cold Spring Harbor Laboratorys (CSHL) researc... by Joans Legacy: The Joan Scarangello Foundation ...nd CSHLs pioneering lung cancer research involving...e a trigger in non-small cell lung cancer, the lea..., The mutations, called epidermal growth factor r...
Other Biology News:MIT gas sensor is tiny, quick 2Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant 2
...D.471. Immunogen: Synthetic peptide derived from ...Specificity: Specific for the junctophilin-1 prote...rain and skeletal muscle homogenates frozen mouse ... Western blotting Immunohistochemistry(froz) Immun...
Mouse Anti-Human Laminin beta-1 / gamma-1 complex Monoclonal Antibody, Unconjugated, Clone 612C10 from Santa Cruz Biotechnology, Inc.
Rabbit Anti-JIP 1 Polyclonal Antibody, Unconjugated from BioVision
Mouse Anti-Mouse XBP-1 Monoclonal Antibody, Unconjugated, Clone F-4 from Santa Cruz Biotechnology, Inc.
Biology Products: